Log in to save to my catalogue

Association between the examination rate of treatment‐resistant schizophrenia and the clozapine pres...

Association between the examination rate of treatment‐resistant schizophrenia and the clozapine pres...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f635aee446544dc881aaa2ddba4f8df1

Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study

About this item

Full title

Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study

Publisher

United States: John Wiley & Sons, Inc

Journal title

Neuropsychopharmacology reports, 2022-03, Vol.42 (1), p.3-9

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
The decision to initiate clozapine treatment should be made on an individual basis and may be closely related to the early detection of treatment‐resistant schizophrenia (TRS), although there is evidence that the early use of clozapine results in a better response to treatment. Therefore, we investigated the relationship between the e...

Alternative Titles

Full title

Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f635aee446544dc881aaa2ddba4f8df1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f635aee446544dc881aaa2ddba4f8df1

Other Identifiers

ISSN

2574-173X

E-ISSN

2574-173X

DOI

10.1002/npr2.12218

How to access this item